Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Measurement of the 2S_{1/2}-8D_{5/2} Transition in Hydrogen.
Brandt AD, Cooper SF, Rasor C, Burkley Z, Matveev A, Yost DC. Brandt AD, et al. Among authors: rasor c. Phys Rev Lett. 2022 Jan 14;128(2):023001. doi: 10.1103/PhysRevLett.128.023001. Phys Rev Lett. 2022. PMID: 35089737
Lyman-α source for laser cooling antihydrogen.
Gabrielse G, Glowacz B, Grzonka D, Hamley CD, Hessels EA, Jones N, Khatri G, Lee SA, Meisenhelder C, Morrison T, Nottet E, Rasor C, Ronald S, Skinner T, Storry CH, Tardiff E, Yost D, Martinez Zambrano D, Zielinski M. Gabrielse G, et al. Among authors: rasor c. Opt Lett. 2018 Jun 15;43(12):2905-2908. doi: 10.1364/OL.43.002905. Opt Lett. 2018. PMID: 29905720
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.
Moliterno DJ; TENACITY Steering Committee and Investigators. Moliterno DJ, et al. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1001-9. doi: 10.1002/ccd.22876. Epub 2011 Jan 11. Catheter Cardiovasc Interv. 2011. PMID: 21598351 Clinical Trial.
A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.
Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD; PLATINUM Trial Investigators. Stone GW, et al. J Am Coll Cardiol. 2011 Apr 19;57(16):1700-8. doi: 10.1016/j.jacc.2011.02.016. Epub 2011 Apr 4. J Am Coll Cardiol. 2011. PMID: 21470815 Free article. Clinical Trial.
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators. Giugliano RP, et al. N Engl J Med. 2009 May 21;360(21):2176-90. doi: 10.1056/NEJMoa0901316. Epub 2009 Mar 30. N Engl J Med. 2009. PMID: 19332455 Free article. Clinical Trial.
11 results